Also, concluding from the two previous studies, it can be said that not only does HO-1 expression by the leukemic stem and progenitor cells of AML patients makes this gene a good target for treating MRD, but also has prognostic value in determining the response to HSCT. Here, HMOX1 is linked to acute myeloid leukemia.